Bovine VEGF-A quantitates bovine VEGF-A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant bovine VEGF-A.
Bovine VEGF-A quantitates bovine VEGF-A in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant bovine VEGF-A.
VEGF (vascular endothelial growth factor) is a homodimer glycoprotein with disulfide bridges involved in angiogenesis, which promotes tumour progression and metastases. VEGF has a variety of effects on vascular endothelium, including the ability to promote endothelial cell viability, mitogenesis, chemotaxia and vascular permeability. The VEGF family currently includes VEGF-A, VEGF-B, VEGF-C, VEGF-D, VEGF-E, and PIGF. VEGF and its receiving system are the fundamental regulators in the cellular signalling of gastrointestinal genesis. Most tumours have absolute requirement for benzogenesis, and VEGF has been described as the most potent angiogenic cytokine associated with this process. To date, 5 different VEGF isoforms have been described. These isoforms are generated following an alternative splicing from a single VEGF gene. These various isoforms have been shown to bind to two tyrosine kinase flt-1 receptors (VEGFR-1) and FLK-1/KDR (VEGFR-2) receptors, which have been expressed almost exclusively on endothelial cells. VEGF and its high affinity binding receptors, tyrosine kinases FLK1 and FLT1, are considered important for the development of embryonic vasculature. Studies have shown that an alternately spliced form of FLT1 produces a soluble protein, called sFLT1, which binds the high affinity vascular endothelial growth factor, which plays an inhibitory role in angiogenesis. High levels of VEGF are related to POEMS syndrome (polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, skin changes) also known as Cro-Fukase syndrome, which affects several organs in the body.
Sensitivity
Sensitivity of the assay: 0.12 ng/mL.
Measurement range
Dose range: 0.123 to 30 ng/mL.
Duration of dosing
Total duration of dosing: 4 h 45 min.
Samples
Type of sample: Plasma, Serum, Surnatant (Serum volume, 50 µl; plasma, 50 µl; supernatant, 50 µl).
Conjugate
Conjugated: Biotin.
Technical specifications
| General |
| Brand | Invitrogen |
| Supplier ref. (Fisher Scientific) | 17144323 |
| Specifications |
| Accession number | Angiogenic factor; ETID309976.16; eVEGF120; eVEGF164; homologue VEGF121 human; MGC70609; MVCD1; vascular endothelial growth factor of l的ovine; RP1-261G23.1; nameless protein product; VAS; vascular endothelial growth factor; precursor of endothelial growth factor |
| Dose range | 0.123 to 30 ng/mL |
| Sensitivity of the dosage | 0.12 ng/mL |
| Conjugate | Biotin |
| Product type | ELISA |
| Type of sample | Plasma, Serum, Surnatant |
| For use with (equipment) | Colorimetric microplate reader |
| Genetic identification (Enter) | P15691 |
| Gene symbol(s) | VEGFA analysis |
| Coefficient of inter-dose variation | <12% |
| Coefficient of intra-dose variation | <10% |
| Contents of kits | Pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids |
| Marker or dye | HRP |
| Quantity | 96 tests |
| Regulatory status | Use exclusively for research |
| Target | VEGF analysis |
| Test time | 1 h 20 min |
| Physical characteristics |
| Volume of sample | Serum, 50 µl; plasma, 50 µl; supernatant, 50 µl |
| Storage and shipping |
| Storage conditions | 2°C to 8°C |
| Total duration of dosing | 4 h 45 min |
Origin and customs
| Manufacturer ref. | EB17RB |
|---|
| Country of origin | United States |
|---|
| HS customs code | 3002 12 00 00 |
|---|
A question or a specific configuration?
Contact us for a quote.